These findings show how AI applications ... can support clinicians at one of the most consequential decision points in ...
According to a study published in the American Journal of Roentgenology (AJR), upgrade and downgrade rates from targeted biopsy to radical prostatectomy were not significantly different between ...
A scoring system radiologists use to determine the risk of clinically significant prostate cancer (PCa) on multiparametric magnetic resonance imaging (mpMRI) scans often produces false positives, with ...
Survival impact of initial local therapy selection for men under 60 with high risk prostate cancer. Prostate cancer (PCa) in 696 hypogonadal men with and without long-term testosterone therapy (TTh): ...
Using a targeted biopsy-only approach for PI-RADS 3 lesions misses clinical significant prostate cancers in a large subset of men. Omitting systematic biopsy after multiparametric magnetic resonance ...
Sequential flotufolastat-F18 PSMA-PET scans to enhance detection of prostate cancer in patients with early PSA recurrence following radical prostatectomy. Prevalence of treatment-acquired homozygous ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results